Brevan Howard Capital Management LP Invests $495,000 in Astrana Health, Inc. (NASDAQ:ASTH)

Brevan Howard Capital Management LP acquired a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 15,706 shares of the company's stock, valued at approximately $495,000.

A number of other hedge funds also recently modified their holdings of ASTH. Pilgrim Partners Asia Pte Ltd acquired a new stake in Astrana Health in the 4th quarter worth about $40,000. Quarry LP grew its holdings in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares during the last quarter. KBC Group NV boosted its holdings in shares of Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after acquiring an additional 1,316 shares in the last quarter. US Bancorp DE boosted its holdings in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after acquiring an additional 4,656 shares in the last quarter. Finally, Pictet Asset Management Holding SA grew its holdings in Astrana Health by 21.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock worth $223,000 after acquiring an additional 1,273 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Trading Down 6.4%

NASDAQ:ASTH traded down $1.84 during midday trading on Tuesday, hitting $26.70. 537,175 shares of the company traded hands, compared to its average volume of 284,643. The firm's fifty day moving average is $30.92 and its 200-day moving average is $35.88. Astrana Health, Inc. has a 12-month low of $23.12 and a 12-month high of $63.20. The firm has a market capitalization of $1.50 billion, a P/E ratio of 20.54, a P/E/G ratio of 1.37 and a beta of 1.00. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $620.39 million for the quarter, compared to analysts' expectations of $628.11 million. During the same quarter in the prior year, the business posted $0.31 EPS. The business's quarterly revenue was up 53.4% on a year-over-year basis. On average, sell-side analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ASTH. Stifel Nicolaus decreased their target price on Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Robert W. Baird cut their target price on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Bank of America cut their price objective on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research report on Tuesday, March 4th. Barclays started coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price objective for the company. Finally, Truist Financial reduced their target price on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $53.29.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.